Incretin-based therapies and Pancreatic Cancer risk in Medicare enrollees – new user protocol

21/12/2012
02/07/2024
EU PAS number:
EUPAS3255
Study
Finalised
Documents
Study protocol
Initial protocol
English (246.52 KB - PDF) View document
Study results
Study results
English (304.27 KB - PDF) View document
Study report
Other information